Nolato Pharma Packaging, a global leader in primary plastic pharmaceutical packaging, is set to showcase its innovative solutions at several major industry events across Europe. With decades of experience and a comprehensive offering that includes both standard and custom packaging solutions, Nolato continues to support pharmaceutical and VMS companies with high-quality, cost-efficient packaging developed under stringent quality standards. This fall, Nolato invites you and industry professionals to connect in person and explore the future of pharma packaging.
Event Participation:
The event calendar begins with PDA Universe in Vienna, Austria, from October 21–22, 2025, where Nolato will be present at booth #72. Shortly after, the team will head to CPHI in Frankfurt, Germany, from October 28–30, 2025, at stand 8.0L53, one of the industry’s largest gatherings for pharmaceutical development and manufacturing. In November, Nolato will participate in ELMIA Subcontractor in Jönköping, Sweden, from November 11–13, 2025, at booth B01:72, showcasing its capabilities in contract manufacturing and packaging innovation.
Looking Ahead to 2026:
The new year kicks off with Pharmapack in Paris, France, from January 21–22, 2026, where Nolato will be at booth #A65. This event is a key platform for pharmaceutical packaging and drug delivery systems, offering a chance to explore Nolato’s latest developments in sustainable, high-performance packaging for solid, liquid, and powder formulations.
Contact Nolato:
Nolato’s presence at these events reflects its commitment to innovation, quality, and global collaboration. With over 30 development and production units across Europe, Asia, and North America, Nolato offers end-to-end solutions—from design and development to volume production. Headquartered in Sweden, the company operates under ISO 15378 and PS9000 certifications, with production in cleanroom environments up to class 7. Join Nolato at these events to discover how their packaging solutions can support your next pharmaceutical breakthrough.